Submitted:
07 January 2026
Posted:
08 January 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Aims and Research Questions
2. Materials and Methods
2.1. Design
2.2. Interventions
2.2.1. Positive Psychotherapy (PPT)
2.2.2. Cognitive Behavior Therapy (CBT)
2.3. Participants and Procedure
2.4. Outcome Measures
2.4.1. Primary Outcomes
2.4.2. Secondary Outcomes
2.5. Statistical Analysis
3. Results
3.1. Sample Characteristics
3.2. Primary and Secondary Outcomes
4. Discussion
4.1. Results in Relation to the Literature
4.2. Limitations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kessler, R.C.; Berglund, P.; Demier, O.; Jin, R.; Koretz, D.; Merikangas, K.R.; Rush, A.J.; Walters, E.E.; Wang, P. S. National comorbidity survey replication: The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003, 289(23), 3095–3105. [Google Scholar] [CrossRef] [PubMed]
- Hautzinger, M. Kognitive Verhaltenstherapie bei Depressionen [Cognitive behavioral therapy of depression; Beltz, 2013. [Google Scholar]
- Steel, Z.; Marnane, C.; Iranpour, C.; Chey, T.; Jackson, J. W.; Patel, V.; Silove, D. The global prevalence of common mental disorders: A systematic review and meta-analysis 1980-2013. International Journal of Epidemiology 2014, 43(2), 476–493. [Google Scholar] [CrossRef] [PubMed]
- Cuijpers, P.; Sijbrandij, M.; Koole, S. L.; Andersson, G.; Beekman, A. T.; Reynolds, C. F. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry 2013, 12(2), 137–148. [Google Scholar] [CrossRef] [PubMed]
- Beck, J. S. Cognitive Behavior Therapy: Basics and beyond, 2nd ed.; The Guilford Press, 2011. [Google Scholar]
- Seligman, M. E. P.; Rashid, T.; Parks, A. C. Positive Psychotherapy. American Psychologist 2006, 61(8), 774–788. [Google Scholar] [CrossRef]
- Sin, N. L.; Lyubomirsky, S. Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: A practice-friendly meta-analysis. Journal of Clinical Psychology 2009, 65(5), 467–487. [Google Scholar] [CrossRef]
- Seligman, M. E. P. Flourish: A visionary new understanding of happiness and well-being.; Simon & Schuster, 2011. [Google Scholar]
- Rashid, T.; Seligman, M.E.P. Positive psychotherapy – clinical manual.; Oxford University Press, 2018. [Google Scholar]
- Carr, A.; Finnegan, L.; Griffin, E.; Cotter, P.M.; Hyland, A. A randomized controlled trial of the Say Yes to Life (SYTL) Positive Psychology Group Psychotherapy Program for Depression: An Interim Report. Journal of Contemporary Psychotherapy 2017, 47(3), 153–161. [Google Scholar] [CrossRef]
- Carr, A.; Cullen, K.; Keeney, C.; Canning, C.; Mooney, O.; Chinseallaigh, E.; O’Dowd, A. Effectiveness of positive psychology interventions: A systematic review and meta-analysis. The Journal of Positive Psychology 2020, 16(6), 749–769. [Google Scholar] [CrossRef]
- Ochoa, C.; Casellas-Grau, J.; Vives, A.; Font, A.; Borràs, J.M. Positive psychotherapy for distressed cancer survivors: Posttraumatic growth facilitation reduces posttraumatic stress. International Journal of Clinical Health Psychology 2017, 17(1), 28–37. [Google Scholar] [CrossRef]
- Hoppen, T. H.; Morina, N. Efficacy of positive psychotherapy in reducing negative and enhancing positive psychological outcomes: A meta-analysis of randomised controlled trials. BMJ Open 2021, 11(9), e046017. [Google Scholar] [CrossRef]
- Parks-Sheiner, A. C. Positive psychotherapy: Building a model of empirically supported self-help. Dissertation Abstracts International: Section B: The Sciences and Engineering 2009, 70(6-B), 3792. [Google Scholar]
- Lü, W.; Wang, Z.; Liu, Y. A pilot study on changes of cardiac vagal tone in individuals with low trait positive affect: The effect of positive psychotherapy. International Journal of Psychophysiology 2013, 88(2), 213–217. [Google Scholar] [CrossRef] [PubMed]
- Shoshani, A.; Steinmetz, S. Positive psychology at school: A school-based intervention to promote adolescents’ mental health and well-being. Journal of Happiness Studies 15 2014, 1289–1311. [Google Scholar] [CrossRef]
- Furchtlehner, L. M.; Schuster, R.; Laireiter, A. R. A comparative study of the efficacy of group positive psychotherapy and group cognitive behavioral therapy in the treatment of depressive disorders: A randomized controlled trial. The Journal of Positive Psychology 2020, 15(6), 832–845. [Google Scholar] [CrossRef]
- Schaub, A.; Roth, E.; Goldmann, U. Kognitive-psychoedukative Therapie zur Bewältigung von Depressionen. Ein Therapiemanual [Cognitive-psychoeducational therapy for coping with depression. A therapy manual; Hogrefe, 2006. [Google Scholar]
- Rosendahl, J.; Alldredge, C. T.; Burlingame, G. M.; Strauss, B. Recent developments in group psychotherapy research. American Journal of Psychotherapy 2021, 74(2), 52–59. [Google Scholar] [CrossRef]
- David, D.; Cristea, I.; Hofmann, S. G. Why cognitive behavioral therapy is the current gold standard of psychotherapy. Frontiers in Psychiatry 2018, 9, 4. [Google Scholar] [CrossRef]
- Furchtlehner, L. M.; Fischer, E.; Schuster, R.; Laireiter, A. R. A comparative study on the efficacy of group positive psychotherapy and group cognitive behavioral therapy on flourishing, happiness and satisfaction with life: A randomized controlled trial. Journal of Happiness Studies 2024, 25(7), 104. [Google Scholar] [CrossRef]
- Seligman, M. E. P.; Steen, T. A.; Park, N.; Peterson, C. Positive psychology progress: Empirical validation of interventions. American Psychologist 2005, 60(5), 410–421. [Google Scholar] [CrossRef]
- Kaluza, G. Stressbewältigung – Trainingsmanual zur psychologischen Gesundheitsförderung (3. Aufl). [Coping – Manual for psychological health promotion (3rd ed.)]. Springer, 2015. [Google Scholar]
- Lutz, R. Genusstherapie [Savouring therapy]. In Verhaltenstherapiemanual [Behavior therapy manual], 7th ed.; Linden, M., Hautzinger, M., Eds.; Springer, 2011; pp. 389–391. [Google Scholar]
- Faul, F.; Erdfeler, E.; Lang, A. G.; Buchner, A. G*Power: A flexible statistical power analyses program for the social, behavioral, and biomedical sciences. Behavioral Research Methods 2007, 39(2), 175–191. [Google Scholar] [CrossRef]
- Wittchen, H.U.; Zaudig, M.; Fydrich, T. SKID: Strukturiertes Klinisches Interview für DSM-IV [SCID: Structured Clinical Interview for DSM-IV; Hogrefe, 1997. [Google Scholar]
- Rashid, T. Positive psychotherapy Inventory.; Unpublished manuscript; University of Pennsylvania, 2005. [Google Scholar]
- Esch, T.; Jose, G.; Gimpel, C.; Von Scheidt, C.; Michalsen, A. Die Flourishing Scale (FS) von Diener et al. liegt jetzt in einer autorisierten deutschen Fassung (FS-D) vor: Einsatz bei einer Mind-Bodymedizinischen Fragestellung [German validation (FS-D) of the Flourishing Scale (FS) by Diener et al.: A mind-body medical question]. Forschende Komplementärmedizin 2013, 20, 267–275. [Google Scholar] [CrossRef]
- Diener, E.; Emmons, R. A.; Larsen, R. J.; Griffin, S. The Satisfaction with Life Scale. Journal of Personality Assessment 1985, 49, 71–75. [Google Scholar] [CrossRef]
- Beck, A. T.; Steer, R. A.; Brown, G. K. BDI-II. Beck Depression Inventory: Manual, 2nd ed.; Harcourt Brace, 1996. [Google Scholar]
- Hautzinger, M.; Keller, F.; Kühner, C. BDI-II - Beck-Depressions-Inventar - Revision. Manual [Beck Depression Inventory – Revision. Manual; Pearson Assessment, 2006. [Google Scholar]
- McGreal, R.; Joseph, S. The Depression-Happiness Scale. Psychological Reports 1993, 73(3_suppl), 1279–1282. [Google Scholar] [CrossRef]
- Montgomery, S. A.; Asberg, M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134(3), 382–389. [Google Scholar] [CrossRef]
- Franke, G. H. BSI. Brief Symptom Inventory. In Manual.; Beltz, 2000. [Google Scholar]
- RStudio Team. RStudio [Computer software] 2023.
- Kuznetsova, A.; Brockhoff, P. B.; Christensen, R. H. B. lmerTest: Tests in linear mixed effects models [R package]. 2016. Available online: https://CRAN.R-project.org/package=lmerTest.
- Cohen, J. Statistical power analysis for the behavioral sciences, 2nd ed.; Lawrence Erlbaum Associates, 1988. [Google Scholar]
- Lim, W. L.; Tierney, S. The effectiveness of positive psychology interventions for promoting well-being of adults experiencing depression compared to other active psychological treatments: A systematic review and meta-analysis. Journal of Happiness Studies 2022, 24(1), 249–273. [Google Scholar] [CrossRef]

| Session | Content |
|---|---|
| 1. Orientation | Topic: The absence of positive resources in maintaining depression HW: Clients introduce themselves through a story in which they share a real-life event showing them at their best |
| 2. Character Strengths | Topic: Defining character strengths and discussion about their role in problem solving HW: Clients complete an online task (SSQ; Signature Strengths Questionnaire) |
| 3. Signature Strengths | Topic: Computing Signature Strengths; discussion about goal setting to target specific problems or to cultivate more engagement HW: Clients frame specific goals into a concrete Signature Strengths Action Plan (SSAP) |
| 4. Good & Bad Memories | Topic: Bad and bitter memories and how they perpetuate psychological distress; discussion about positive cognitive reappraisal strategies HW: Clients write about 3 bad memories and reflect on their impact in maintaining depression |
| 5. Forgiveness | Topic: Forgiveness as a potential option to transform feelings of anger and bitterness HW: forgiveness letter |
| 6. Gratitude | Topic: Gratitude as an enduring thankfulness; discussion about good and bad memories with an emphasis on gratitude. HW: gratitude letter |
| 7.Mid-Therapy-Feedback Session | Topic: Signature Strengths Action Plan; follow-up of the forgiveness and gratitude assignments; necessary changes are made |
| 8. Satisficing vs. Maximizing | Topic: Concepts of satisficing & maximizing and discussion about one’s own level HW: Clients identify and plan areas where they can benefit from satisficing |
| 9. Hope, Optimism & Posttraumatic Growth | Topic: Optimism and hope in detail (clients think and write about times when important things were lost but other opportunities opened up); potential growth from trauma is also explored and specific strategies are discussed to explore optimism in everyday life HW: Specific strategies to exercise optimism in everyday life |
| 10. Positive Relationships | Topic: the role and importance of positive relationships in well-being Clients practise Active-Constructive Responding (ACR) - a strategy to foster positive relationship communication HW: Clients self-monitor for active-constructive opportunities |
| 11. Signature Strengths of Others | Topic: Identification of character strengths of other family members HW: Clients ask family members to complete the SSQ online task and draw a family tree of strengths; discussion about family member’s signature strengths |
| 12. Savouring | Topic: Savouring and its types and techniques with a savouring exercise; strategies to safeguard against adaption HW: Clients plan a savouring activity using specific techniques |
| 13. Altruism | Topic: the therapeutic benefits of helping others HW: Clients plan to give a gift of time to someone using their signature strengths |
| 14. The Full Life | Topic: Integration: The Full Life as the integration of positive emotions, engagement, positive relationship, meaning and accomplishment; discussion about therapeutic gains and experiences and ways to sustain positive changes are devised |
| Topic | Session | Description | |
|---|---|---|---|
| Psychoeducation | 1 | - Introduction - Organizational issues - Therapy concept - Dos and don’ts of how to behave in groups - Symptoms |
|
| 2 | - Vulnerability stress model and vulnerability stress coping model | ||
| 3 | - Medication and how do antidepressants work - Other treatment strategies and psychotherapeutic approaches |
||
| Behavioral activation | 4 | - The vicious circle of depression - The depression spiral effect |
|
| 5 | - Positive activities and how to plan them | ||
| 6 | - Importance of balance between positive activities and requirements / challenges (self-reinforcement) | ||
| Cognitive therapy | 7 | - Introduction of cognitive behavioral therapy - The cognitive triad of depression - The A-B-C theory |
|
| 8 | - Cognitive distortions and how to change them - How to stop rumination |
||
| 9 | - Typical depressive core beliefs and how they are influenced by automatically depressive thoughts | ||
| 10 | - Identifying and changing depressive core beliefs | ||
| Relapse prevention | 11 | - Early warning signs of depression - Relapse prevention based on medication - How to deal with crises |
|
| 12 | - How to handle depression - Follow-up care - Conclusion |
||
| Extra session 1 | 13 | - Stress management: how depression is influenced by stress - Stressors and automatically running thoughts - Stress reaction (thoughts, emotions, physical reaction, behavior) - Stress management strategies (instrumental, cognitive, palliative-regenerative) |
|
| Extra session 2 | 14 | - Savouring: how depression is influenced by a lack of savouring - Savouring strategies comprising all sensory perceptions (taste, olfaction, tactile sense, sense of sight, sense of hearing) |
|
| Treatment group (PPT) (n = 46) |
Control group (CBT) (n = 46) |
Total (N = 92) |
Statistics | |
|---|---|---|---|---|
| Demographic characteristics | ||||
| Gender: n (%) | Female: 31 (67.4) |
Female: 28 (60.9) |
Female: 59 (64.1) |
χ2 (1, N = 92) = 0.43, p = .43 |
| Age: Mean (SD) | 39.78 (11.53) | 41.46 (13.35) | 40.66 (12.4) | t(90) = -0.61, p = .54 |
| Education: ≥ 9 years: n (%) | 15 (32.6) | 17 (36.9) | 32 (34.8) | χ2 (3, N = 92) = 3.07, p = .38 |
| ≥ 12 years: n (%) | 21 (45.7) | 16 (34.8) | 37 (40.2) | |
| ≥ 16 years n (%) | 10 (21.7) | 13 (28.3) | 23 (25.0) | |
| Applied instruments | ||||
| BDI-II: Mean (SD) | 24.4 (10.83) | 25.17 (11.22) | 24.61 (10.99) | t(90) = -0.49, p = .62 |
| MADRS: Mean (SD) | 21.04 (8.22) | 22.80 (9.80) | 21.91 (9.07) | t(88) = -0.92, p = .36 |
| DHS: Mean (SD) | 33.46 (15.60) | 32.74 (16.51) | 33.10 (15.98) | t(90) = 0.21, p = .83 |
| BSI: Mean (SD) | 1.12 (0.57) | 1.22 (0.69) | 1.17 (0.63) | t(90) = -0.76, p = .45 |
| PPTI_total: Mean (SD) | 78.93 (13.36) | 76.54 (16.18) | 77.74 (17.81) | t(90) = 0.77, p = .44 |
| FS: Mean (SD) | 35.33 (8.56) | 33.61 (8.91) | 34.47 (8.73) | t(90) = 0.94, p = .35 |
| SWLS: Mean (SD) | 17.17 (6.00) | 17.09 (6.85) | 17.13 (6.41) | t(90) = 0.07, p = .95 |
| Drop Out (Pre to post) | n = 11 | n = 9 | n = 20 | χ2 (1, N = 92) = 0.26, p = .61 |
| Drop Out (Pre to 6 months follow-up) | n = 15 | n = 16 | n = 31 | χ2 (1, N = 92) = 0.05, p = .83 |
| Drop Out (Pre to 18 months follow-up) | n = 20 | n = 23 | n = 43 | χ2 (1, N = 92) = 0.39, p = .53 |
| Clinical characteristics of Diagnosis by SKID-I | χ2 (7, N = 92) = 5.57, p = .59 | |||
| Single Episode of Major depression | ||||
| mild: n (%) | 1 (2.2) | 2 (4.3) | 3 (3.3) | |
| moderate: n (%) | 10 (21.7) | 6 (13.0) | 16 (17.4) | |
| partial in remission: n (%) | 1 (2.2) | 3 (6.5) | 4 (4.3) | |
| Recurrent Major depression | ||||
| currently mild: n (%) | 1 (2.2) | 4 (8.7) | 5 (5.4) | |
| currently moderate: n (%) | 24 (52.2) | 23 (50.0) | 47 (51.1) | |
| currently partial in remission: n (%) | 1 (2.2) | 0 (0.0) | 1 (1.1) | |
| Dysthymia | ||||
| with double depression: n (%) | 6 (13) | 7 (15.2) | 13 (14.1) | |
| without double depression: n (%) | 2 (4.3) | 1 (2.2) | 3 (3.3) | |
| Severity of depression | ||||
| partial in remission: n (%) | 2 (5.2) | 3 (7.8) | 5 (5.4) | |
| mild: n (%) | 2 (5.2) | 6 (15.8) | 8 (8.7) | |
| moderate: n (%) | 34 (89.5) | 29 (76.3) | 63 (68.5) | |
| Applied instruments | Preintervention | 18 months follow-up | Statistics at baseline (pairwise comparisons between PPT and CBT) | ||
|---|---|---|---|---|---|
| PPT | CBT | PPT | CBT | ||
| M (SE) | M (SE) | M (SE) | M (SE) | ||
| SWLS | 17.4 (0.67) | 17.3 (0.67) | 23.0 (0.72)ab | 18.3 (0.72) | t(1, 223) = 0.01, p = .99, η²p = .00 |
| FS | 34.6 (0.93) | 34.3 (0.93) | 41.3 (1.00)ab | 37.1 (1.01) | t(1, 223) = 0.26, p = .79, η²p = .00 |
| PPTI_total | 77.9 (1.48) | 77.4 (1.49) | 89.2 (1.60)ab | 82.1 (1.60) | t(1, 219) = 0.21, p = .84, η²p = .00 |
| PPTI_P | 13.9 (0.42) | 13.6 (0.42) | 17.5 (0.45)ab | 14.9 (0.45) | t(1, 246) = 0.27, p = .65, η²p = .00 |
| PPTI_E | 16.6 (0.40) | 16.6 (0.40) | 19.3 (0.43)ab | 17.5 (0.43) | t(1, 213) = 0.00, p = 1.00, η²p = .00 |
| PPTI_R | 17.5 (0.40) | 17.5 (0.40) | 19.1 (0.44)b | 18.1 (0.44) | t(1, 233) = -0.11, p = .91, η²p = .00 |
| PPTI_M | 13.9 (0.36) | 13.7 (0.36) | 15.6 (0.38)ab | 14.5 (0.39) | t(1, 235) = 0.38, p = .70, η²p = .00 |
| PPTI_A | 15.9 (0.38) | 15.9 (0.38) | 17.6 (0.41)b | 17.1 (0.41)b | t(1, 208) = 0.14, p = .89, η²p = .00 |
| DHS | 32.9 (1.90) | 32.7 (1.91) | 47.8 (2.05)ab | 35.0 (2.06) | t(1, 233) = 0.08, p = .93, η²p = .00 |
| MADRS | 21.3 (1.07) | 22.01 (1.10) | 9.10 (1.15)ab | 13.95 (1.19)b | t(1, 236) = -0.45, p = .66, η²p = .00 |
| BDI-II | 24.85 (1.33) | 25.18 (1.33) | 9.99 (1.43)ab | 21.48 (1.43) | t(1, 223) = -0.18, p = .86, η²p = .00 |
| BSI | 1.14 (0.06) | 1.16 (0.06) | 0.60 (0.07)ab | 1.11 (0.07) | t(1, 229) = -0.29, p = .78, η²p = .00 |
| Fixed effects (intercepts, slopes) | Est | SE | t | p | 95% CI LL | 95% CI UL |
partial η2 |
|---|---|---|---|---|---|---|---|
| SWLS Intercept Treatment Time Site SWLS_T1 Treatment × Time |
2.55 0.12 2.91 -0.42 0.86 -1.19 |
2.31 1.20 0.70 0.75 0.06 0.45 |
1.10 0.10 4.15 -0.56 15.16 -2.66 |
.271 .923 <.001 .575 <.001 .008 |
-1.98 -2.23 1.54 -1.88 0.75 -2.07 |
7.09 2.46 4.28 1.04 0.97 -0.31 |
0.00 0.00 0.07 0.00 0.72 0.03 |
| FS Intercept Treatment Time Site FS_T1 Treatment × Time |
8.77 -1.04 2.35 -0.78 0.80 -0.34 |
3.51 1.66 0.97 1.03 0.06 0.62 |
2.50 -0.63 2.44 -0.76 14.06 -0.56 |
.013 .530 .016 .451 <.001 .579 |
1.90 -4.30 0.46 -2.80 0.69 -1.56 |
15.64 2.21 4.25 1.24 0.91 0.87 |
0.03 0.00 0.03 0.00 0.69 0.00 |
| PPTI_total Intercept Treatment Time Site PPTI_total_T1 Treatment × Time |
14.82 -1.54 4.03 0.06 0.82 -0.80 |
6.24 2.65 1.54 1.64 0.05 0.99 |
2.37 -0.58 2.62 0.04 15.28 -0.81 |
.019 .563 .009 .967 <.001 .416 |
2.58 -6.74 1.01 -3.15 0.72 -2.73 |
27.06 3.66 7.05 3.29 0.93 1.13 |
0.03 0.00 0.03 0.00 0.72 0.00 |
| PPTI_P Intercept Treatment Time Site PPTI_P_T1 Treatment × Time |
4.21 -0.88 1.13 -0.41 0.81 -0.12 |
1.56 0.77 0.46 0.42 0.06 0.30 |
2.69 -1.14 2.44 -0.98 14.43 -0.40 |
.008 .253 .015 .330 <.001 .693 |
1.14 -2.38 0.22 -1.24 0.70 -0.70 |
7.27 0.62 2.03 0.41 0.92 0.46 |
0.03 0.00 0.03 0.01 0.69 0.00 |
| PPTI_E Intercept Treatment Time Site PPTI_E_T1 Treatment × Time |
4.08 -0.18 1.26 0.59 0.69 -0.35 |
1.55 0.70 0.40 0.47 0.06 0.26 |
2.64 -0.26 3.14 1.26 10.76 -1.36 |
.009 .792 .002 .210 <.001 .174 |
1.05 -1.55 0.47 -0.32 0.57 -0.85 |
7.12 1.19 2.04 1.50 0.82 0.15 |
0.04 0.00 0.04 0.02 0.55 0.00 |
| PPTI_R Intercept Treatment Time Site PPTI_R_T1 Treatment × Time |
3.61 0.14 0.77 0.21 0.75 -0.26 |
1.53 0.71 0.42 0.42 0.04 0.27 |
2.37 0.19 1.85 0.50 17.09 -0.96 |
.019 .846 .065 .616 <.001 .338 |
0.62 -1.26 -0.04 -0.61 0.67 -0.78 |
6.60 1.53 1.59 1.03 0.84 0.27 |
0.03 0.00 0.01 0.00 0.77 0.00 |
| PPTI_M Intercept Treatment Time Site PPTI_M_T1 Treatment × Time |
3.67 -0.51 0.39 -0.17 0.80 0.00 |
1.33 0.63 0.37 0.37 0.05 0.24 |
2.75 -0.80 1.06 -0.47 16.98 0.02 |
.007 .424 .292 .637 <.001 .988 |
1.05 -1.74 -0.34 -0.89 0.70 -0.46 |
6.28 0.73 1.12 0.54 0.89 0.47 |
0.04 0.00 0.00 0.00 0.77 0.00 |
| PPTI_A Intercept Treatment Time Site PPTI_A_T1 Treatment × Time |
3.88 -0.11 0.52 0.32 0.74 -0.12 |
1.48 0.67 0.38 0.43 0.06 0.24 |
2.63 -0.17 1.37 0.74 13.20 -0.49 |
.009 .869 .172 .460 <.001 .623 |
0.99 -1.41 -0.22 -0.52 0.63 -0.59 |
6.77 1.19 1.26 1.16 0.84 0.35 |
0.04 0.00 0.00 0.00 0.64 0.00 |
| DHS Intercept Treatment Time Site DHS_T1 Treatment × Time |
5.52 -0.49 8.40 2.11 0.69 -3.06 |
6.42 3.41 2.00 2.05 0.06 1.28 |
0.86 -0.14 4.19 1.03 10.96 -2.39 |
.391 .886 <.001 .305 <.001 .018 |
-7.07 -7.16 4.47 -1.90 0.57 -5.58 |
18.10 6.19 12.33 6.12 0.81 -0.55 |
0.00 0.00 0.07 0.01 0.56 0.02 |
| MADRS Intercept Treatment Time Site MADS_T1 Treatment × Time |
5.68 0.54 -5.07 1.90 0.60 1.26 |
4.46 2.08 1.25 1.28 0.07 0.80 |
1.27 0.26 -4.04 1.49 8.52 1.56 |
.200 .790 <.001 .140 <.001 .120 |
-3.05 -3.54 -7.52 -0.60 0.46 -0.32 |
14.42 4.62 -2.61 4.40 0.74 2.84 |
0.00 0.00 0.07 0.02 0.45 0.01 |
| BDI Intercept Treatment Time Site BDI_T1 Treatment × Time |
7.62 1.41 -6.55 -0.53 0.70 1.97 |
5.31 2.47 1.46 1.58 0.07 0.94 |
1.43 0.57 -4.48 -0.33 10.00 2.11 |
.153 .568 <.001 .739 <.001 .036 |
-2.80 -3.43 -9.41 -3.63 0.56 0.14 |
18.03 6.26 -3.69 2.57 0.83 3.80 |
0.01 0.00 0.08 0.00 0.53 0.02 |
| BSI Intercept Treatment Time Site BSI_T1 Treatment × Time |
0.15 0.09 -0.25 0.04 0.75 0.09 |
0.24 0.11 0.07 0.07 0.06 0.04 |
0.63 0.75 -3.73 0.59 13.01 2.06 |
.530 .452 <.001 .556 <.001 .041 |
-0.32 -0.14 -0.39 -0.10 0.64 0.00 |
0.62 0.31 -0.12 0.19 0.86 0.17 |
0.00 0.00 0.06 0.00 0.65 0.02 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).